NICE guidance on stents

NICE has published its final draft guidance on the use of drug-eluting stents for the treatment of coronary artery disease (CAD).

The draft guidance recommends the use of drug-eluting stents (DES) for those patients who are at higher risk of needing further stents if a conventional bare-metal stent (BMS) were used instead. These patients have a coronary artery less than 3 mm in diameter, or the segment of the artery to be treated is longer than 15 mm.

The draft guidance also states that drug eluting stents should only be used if the price difference between it and a bare metal stent is no more than £300.

Latest Issues

AfPP Regional Conference – Nottingham

Business School, University of Nottingham
20th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

AfPP Regional Conference – Oxford

Mathematical Institute, University of Oxford
4th October 2025

BACCN Conference 2025

Blackpool
7th - 8th October 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025